Add to ORKGThe ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia highlights the need for more effective control strategies. A new regimen to treat MDR-TB that includes pyrazinamide (PZA) is currently being evaluated and PZA resistance status will largely influence the success of current and future treatment strategies. PZA susceptibility testing was not routinely performed at the National Reference Laboratory (NRL) in Tbilisi between 2010 and September 2015. We here provide a first insight into the prevalence of PZA resistant TB in this region
Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is no...
AbstractIt has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosi...
Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemoth...
Abstract Background The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia hig...
BACKGROUND: The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia highlights ...
Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability to eradicate...
<div><p>Background</p><p>Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its un...
AbstractAims and objectivesThe aim of this study is to determine the prevalence of pyrazinamide (PZA...
It has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosis is cor...
International audienceBackground: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) str...
Besides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd ...
International audienceBackground: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) str...
Abstract Background Tuberculosis (TB) is the leading cause of death from an infectious disease and t...
Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summariz...
Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summariz...
Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is no...
AbstractIt has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosi...
Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemoth...
Abstract Background The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia hig...
BACKGROUND: The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia highlights ...
Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability to eradicate...
<div><p>Background</p><p>Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its un...
AbstractAims and objectivesThe aim of this study is to determine the prevalence of pyrazinamide (PZA...
It has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosis is cor...
International audienceBackground: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) str...
Besides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd ...
International audienceBackground: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) str...
Abstract Background Tuberculosis (TB) is the leading cause of death from an infectious disease and t...
Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summariz...
Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summariz...
Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is no...
AbstractIt has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosi...
Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemoth...